Anastrozole Administration in Elderly Hypogonadal Men

Completed · Phase 2 · Has a placebo group

Conditions studied: Hypogonadism

In brief

The purpose of the study is to assess the effects of sustained aromatase inhibitor therapy to reduce estrogen levels in elderly men with mild hypogonadism (a decreased level of sex hormones).

Key facts

Study ID

NCT00136695

Run by

Massachusetts General Hospital

People needed

88

Starts

2004-10-01

Expected to finish

2009-10-01

Last updated by the study team

2022-09-13

Who can join

Age: 60 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men ages 60 and older
• Serum testosterone between 150-300 ng/dL
• Symptoms suggestive of androgen deficiency

Where it is running

• General Clinical Research Center, Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.